Gómez-Ochoa, Sergio Alejandro
Rojas, Lyda Z.
Echeverría, Luis Eduardo
Article History
Accepted: 15 September 2023
First Online: 16 October 2023
Declarations
:
: The institutional Ethics Committee of the Fundación Cardiovascular de Colombia approved the EMPA-Chagas study (CEI-2023–05269).
: All patients provided their written informed consent for participation.
: All authors agree to the publication of the manuscript in its present form.
: SAGO, LZR, and LEE received funding from Boehringer Ingelheim S.A. for the development of the EMPA-Chagas Study.